glp 1 receptor drugs Frontiers The New - GLP-1 receptor

Mechanisms of action GLP-1RAs have become notable for their ability to reduce glucose levels and their emerging function as anti-inflammatory agents

The GLP-1 drug revolution has changed how the world thinks about weight loss

In a randomised controlled trial with over 1800 participants comparing tirzepatide to semaglutide, the tirzepatide group reported more serious adverse events (5-7% VS 3%) and higher discontinuation rates due to adverse events (6-8.5% VS 4%)

Why are investors betting on combination therapies like CagriSema over single-drug approaches

Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-B in mice